AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
Kentaroh Yamamoto(The University of Tokyo), Norihiro Kokudo(National Center for Global Health and Medicine), Yukio Kume(The University of Tokyo), Hitoshi Ikeda(Dokkyo Medical University), Kiyoshi Hasegawa(Bunkyo University), Taku Aoki(Dokkyo Medical University), Hiroshi Imamura(Shinshu University), Gary L. Norman(Nova Medical (United States)), Yoshifumi Beck(The University of Tokyo), Yutaka Matsuyama(The University of Tokyo), Zakera Shums(Nova Medical (United States)), Yasuhiko Sugawara(Kumamoto University)
Cited by 192
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
The Rubble-Pile Asteroid Itokawa as Observed by Hayabusa
|Science|2006|975
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780